Promotion of prescription drugs and its impact on physicians' choice behavior

FF Gönül, F Carter, E Petrova… - Journal of …, 2001 - journals.sagepub.com
The authors investigate whether and how pricing and promotional activities influence
prescription choice behavior using a comprehensive panel of physicians and data on …

Pharmaceutical innovations and market dynamics: Tracking effects on price indexes for antidepressant drugs

ER Berndt, IM Cockburn, Z Griliches, TE Keeler… - Brookings Papers on …, 1996 - JSTOR
THE CONSTRUCTION AND PUBLICATION of measures of price inflation are important
tasks carried out by governmental statistical agencies. In the United States the Department …

Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary …

A Paraponaris, P Verger, B Desquins, P Villani… - Health Policy, 2004 - Elsevier
France presents a unique situation in which the take-off of a generic drug market depends,
out of regulatory incentives, on whether physicians choose a prescription method …

Do pharmaceutical marketing activities raise prices? Evidence from five major therapeutic classes

ML Capella, CR Taylor, RC Campbell… - Journal of Public …, 2009 - journals.sagepub.com
The impact of direct-to-consumer (DTC) advertising of prescription drugs on consumers has
become the focus of considerable debate. Given rising health care costs, the question …

Competition between brand‐name and generics–analysis on pricing of brand‐name pharmaceutical

Y Kong - Health economics, 2009 - Wiley Online Library
The objective of this paper is to provide two‐stage game models explaining the 'Generic
Competition Paradox'that demonstrates an increase of brand‐name drug price in response …

[PDF][PDF] Bens credenciais e poder de mercado: um estudo econométrico da indústria farmacêutica brasileira

EPS Fiuza, MB Lisboa - 2001 - repositorio.ipea.gov.br
No Brasil, o alto peso dos gastos em medicamentos no consumo das famílias,
principalmente as mais pobres, e os reajustes de preço tradicionalmente acima dos índices …

[图书][B] The pharmaceutical industry: a discussion of competitive and antitrust issues in an environment of change

R Levy - 1999 - books.google.com
Over the last 15 years, the pricing and other competitive strategies of pharmaceutical
companies have been altered by revolutionary developments in information technology …

Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia

J Costa-Font, P Kanavos, J Rovira - Applied Economics, 2007 - Taylor & Francis
This article examines the determinants of the demand for pharmaceuticals in Catalonia
using the latest available official survey data, having accounted for the individual differences …

Pricing and patents of HIV/AIDS drugs in developing countries

JR Borrell - Applied economics, 2007 - Taylor & Francis
This article provides empirical evidence on the impact of patents on drug prices across
developing countries. It uses sales data on human immunodeficiency virus (HIV)/acquired …

Can health insurance coverage explain the generic competition paradox?

I Ferrara, Y Kong - Economics Letters, 2008 - Elsevier
Can health insurance coverage explain the generic competition paradox? - ScienceDirect Skip
to main contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View …